Volume 73, Pages 173-179 (August 2017) Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study Rafael Toledano, Camilo Espinosa Jovel, Adolfo Jiménez-Huete, Pau Giner Bayarri, Dulce Campos, Elena López Gomariz, Beatriz González Giráldez, Irene García-Morales, Mercé Falip, Paula Martínez Agredano, Susana Palao, María José Aguilar Amat Prior, María Rosa Querol Pascual, Francisco José Navacerrada, Francisco Javier López González, Joaquín Ojeda, Aránzazu Alfaro Sáez, Pedro Emilio Bermejo, Antonio Gil-Nagel Epilepsy & Behavior Volume 73, Pages 173-179 (August 2017) DOI: 10.1016/j.yebeh.2017.02.028 Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 1 a. Reduction in seizures at 3months (n=95). b. Reduction in seizures at 3months (n=95) by subgroup. Epilepsy & Behavior 2017 73, 173-179DOI: (10.1016/j.yebeh.2017.02.028) Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 2 a. Reduction in seizures at 6months (n=84). b. Reduction in seizures at 6months (n=84) by subgroup. Epilepsy & Behavior 2017 73, 173-179DOI: (10.1016/j.yebeh.2017.02.028) Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 3 a. Reduction in seizures at 12months (n=59). b. Reduction in seizures at 12months (n=59) by subgroup. Epilepsy & Behavior 2017 73, 173-179DOI: (10.1016/j.yebeh.2017.02.028) Copyright © 2017 Elsevier Inc. Terms and Conditions